{
  "doc_id": "02_Article_AAV Management Guidelines",
  "doc_filename": "02_Article_AAV Management Guidelines.pdf",
  "trial_ids": [
    {
      "id_type": "NCT",
      "value": "NCT03942887",
      "registry": "ClinicalTrials.gov",
      "url": "https://clinicaltrials.gov/study/NCT03942887",
      "title": null
    }
  ],
  "study_design": null,
  "eligibility_inclusion": [
    {
      "field_type": "ELIGIBILITY_INCLUSION",
      "text": "adult patients with AAV",
      "section": "eligibility",
      "page": 1,
      "structured_data": {
        "type": "inclusion",
        "category": "diagnosis",
        "derived": null
      },
      "confidence": 0.85,
      "evidence": [
        {
          "page": 1,
          "quote": "These recommendations address the diagnosis and treatment of adult patients with AAV",
          "source_node_id": null,
          "source_doc_id": "02_Article_AAV Management Guidelines"
        }
      ]
    }
  ],
  "eligibility_exclusion": [],
  "epidemiology": [],
  "patient_journey": [],
  "endpoints": [
    {
      "field_type": "STUDY_ENDPOINT",
      "text": "Biomarkers for drug toxicity prediction",
      "section": "endpoints",
      "page": 13,
      "structured_data": {
        "type": "exploratory",
        "name": "Biomarkers for drug toxicity prediction",
        "measure": "Biomarkers",
        "timepoint": "Long-term",
        "analysis_method": null
      },
      "confidence": 0.88,
      "evidence": [
        {
          "page": 13,
          "quote": "Identify biomarkers to predict drug toxicity.",
          "source_node_id": null,
          "source_doc_id": "02_Article_AAV Management Guidelines"
        }
      ]
    },
    {
      "field_type": "STUDY_ENDPOINT",
      "text": "Predictors for treatment response",
      "section": "endpoints",
      "page": 13,
      "structured_data": {
        "type": "exploratory",
        "name": "Predictors for treatment response",
        "measure": "Predictors for good response, remission or relapse",
        "timepoint": "Long-term",
        "analysis_method": null
      },
      "confidence": 0.88,
      "evidence": [
        {
          "page": 13,
          "quote": "Identify predictors for good response, remission or relapse.",
          "source_node_id": null,
          "source_doc_id": "02_Article_AAV Management Guidelines"
        }
      ]
    },
    {
      "field_type": "STUDY_ENDPOINT",
      "text": "Patient-reported outcomes validation",
      "section": "endpoints",
      "page": 13,
      "structured_data": {
        "type": "exploratory",
        "name": "Patient-reported outcomes validation",
        "measure": "Patient-reported outcomes",
        "timepoint": "Clinical practice",
        "analysis_method": null
      },
      "confidence": 0.88,
      "evidence": [
        {
          "page": 13,
          "quote": "Define and validate use of patient-reported outcomes for management of AAV in clinical practice.",
          "source_node_id": null,
          "source_doc_id": "02_Article_AAV Management Guidelines"
        }
      ]
    },
    {
      "field_type": "STUDY_ENDPOINT",
      "text": "Long-term glucocorticoid adverse effects",
      "section": "endpoints",
      "page": 13,
      "structured_data": {
        "type": "safety",
        "name": "Long-term glucocorticoid adverse effects",
        "measure": "GC-related adverse effects and comorbidities",
        "timepoint": "Long-term",
        "analysis_method": null
      },
      "confidence": 0.88,
      "evidence": [
        {
          "page": 13,
          "quote": "Study the impact of long-term GC therapy on GC-related adverse effects and comorbidities.",
          "source_node_id": null,
          "source_doc_id": "02_Article_AAV Management Guidelines"
        }
      ]
    }
  ],
  "sites": [
    {
      "field_type": "STUDY_SITE",
      "text": "United States",
      "section": "sites",
      "page": null,
      "structured_data": {
        "country": "United States",
        "site_count": null
      },
      "confidence": 0.85,
      "evidence": []
    }
  ],
  "operational_burden": {
    "invasive_procedures": [],
    "visit_schedule": {
      "total_visits": null,
      "visit_days": [],
      "frequency": null,
      "duration_weeks": null,
      "scheduled_visits": [],
      "pre_randomization_days": [],
      "on_treatment_days": [],
      "follow_up_days": [],
      "evidence": []
    },
    "central_lab_required": false,
    "central_lab": null,
    "special_sample_handling": [],
    "vaccination_requirements": [],
    "background_therapy": [],
    "concomitant_meds_allowed": [],
    "run_in_duration_days": null,
    "run_in_requirements": [],
    "burden_score": null,
    "site_complexity_score": null,
    "hard_gates": []
  },
  "screening_flow": null,
  "extraction_timestamp": "2026-02-04T14:00:26.221779"
}